?

        當(dāng)前位置:標(biāo)準(zhǔn)品 > 標(biāo)準(zhǔn)物質(zhì) >
        白介素29(干擾素λ,人類,rDNA衍生)WHO參考試劑
        ??【編號】:NIBSC10/176

        ??【名稱】:白介素29(干擾素λ,人類,rDNA衍生)WHO參考試劑

        ??【規(guī)格】:個

        ??【價格】:2600元

          白介素29(干擾素λ,人類,rDNA衍生)WHO參考試劑

          編號:NIBSC10/176
          英文:Interleukin-29 (Interferon Lambda, Human, rDNA derived) WHO Reference Reagent
          標(biāo)準(zhǔn)類型: 非WHO參考資料
          規(guī)格:1個 
          描述:1. INTENDED USE
        This material is intended as a biological reference standard in bioassays
        for IL-29 (Interferon Lamda 1).
        2. CAUTION
        This preparation is not for administration to humans or animals in
        the human food chain.
        The preparation contains human and bovine source material. The
        preparation contains an excipient of human origin which has been
        tested and found negative for HBsAg and HIV antibody. The
        preparation has subsequently been tested and found negative for antiHCV
        and HCV RNA by PCR. The bovine casein used as an excipient
        was sourced from a country where bovine spongiform encephalopathy
        (BSE) has not been found. As with all materials of biological origin,
        this preparation should be regarded as potentially hazardous to health.
        It should be used and discarded according to your own laboratory's
        safety procedures. Such safety procedures should include the wearing
        of protective gloves and avoiding the generation of aerosols. Care
        should be exercised in opening ampoules or vials, to avoid cuts.
        3. UNITAGE
        The assigned potency of the preparation is 5,000 units of biological
        activity per ampoule.
        4. CONTENTS
        Country of origin of biological material: United Kingdom.
        Each ampoule contains the residue after freeze-drying of 1ml of
        phosphate buffered saline that contained:
        Approximately 500 nanograms of recombinant human IL-29
        1.0% human serum albumin
        0.3% bovine casein
        The IL-29 protein was expessed in E.coli.
        The ampoule does not contain bacteriostat.
        5. STORAGE
        For economy of use, it is recommended that the solution be sub-divided
        into several small aliquots and stored at -40oC or below. Avoid repeated
        thawing/freezing. Unopened ampoules should be stored at -20oC.
        Please note: because of the inherent stability of lyophilized material,
        NIBSC may ship these materials at ambient temperature.
        6. DIRECTIONS FOR OPENING
        DIN ampoules have an 'easy-open' coloured stress point, where the
        narrow ampoule stem joins the wider ampoule body. Various types of
        ampoule breaker are available commercially. To open the ampoule,
        tap the ampoule gently to collect material at the bottom (labelled) end
        and follow manufactures instructions provided with the ampoule
        breaker.
        7. USE OF MATERIAL
        No attempt should be made to weigh out any portion of the freeze-dried
        material prior to reconstitutionDissolve the total contents of the ampoule with 0.5ml of sterile distilled
        water. Rinse the ampoule with 0.4ml of sterile distilled water and make up
        the total volume to 1ml with sterile distilled water. This solution should
        now contain IL-29 at a concentration of 5,000 U/ml. Use carrier protein
        where extensive dilution is required. It is recommended that the IL-29
        solution be used immediately or stored as indicated in section5.
        8. STABILITY
        Reference materials are held at NIBSC within assured, temperaturecontrolled
        storage facilities and they should be stored on receipt as
        indicated on the label. It is the policy of WHO not to assign an expiry date
        to their international reference materials. Accelerated degradation studies
        have indicated that this material is suitably stable, when stored at -20?C
        or below, for the assigned values to remain valid until the material is
        withdrawn or replaced. These studies have also shown that the material
        is suitably stable for shipment at ambient temperature without any effect
        on the assigned values. Users who have data supporting any
        deterioration in the characteristics of any reference preparation are
        encouraged to contact NIBSC.
        9. REFERENCES
        This reference reagent was produced under WHO guidelines cited in the
        WHO Technical Reports Series, no. 925, 2005.
          聲明:此對照品、標(biāo)準(zhǔn)品由【中檢計量】提供網(wǎng)站查詢購買服務(wù)
          注:點(diǎn)擊cas,或者搜索:名稱、編號、cas均可顯示價格
        上一篇:白介素2可溶性受體(人類,rDNA衍生) 下一篇:沒有了



          產(chǎn)品推薦 相關(guān)產(chǎn)品

          1. ·GBW(E)090272???人類免疫缺陷病毒核酸(HIV-1 RNA)系列血清(液體)標(biāo)準(zhǔn)物質(zhì)
          2. ·GBW(E)080474???甲醇中4-硝基酚溶液標(biāo)準(zhǔn)物質(zhì)
          3. ·GBW07310(GSD-10)???水系沉積物成分分析標(biāo)準(zhǔn)物質(zhì)
          4. ·GBW(E)080186???水中磷成分分析標(biāo)準(zhǔn)物質(zhì)
          5. ·GBW13968???GBW13968 二氧化硅納米薄膜厚度標(biāo)準(zhǔn)物質(zhì)
          6. ·GBW01635???鐵鎳基鑄造高溫合金雜質(zhì)成分分析標(biāo)準(zhǔn)物質(zhì)
          7. ·BW100300???鄰苯二甲酸二異辛酯溶液標(biāo)準(zhǔn)物質(zhì)(1.00mg/mL)
          8. ·BW0722???甲醇中環(huán)己烷溶液標(biāo)準(zhǔn)物質(zhì)(1000μg/ml)
          9. ·GBW(E)100174???咖啡因溶液標(biāo)準(zhǔn)物質(zhì)
          10. ·GBW(E)061891???呋喃唑酮純度標(biāo)準(zhǔn)物質(zhì)

          ?
          首 頁 | 對照品| 標(biāo)準(zhǔn)品| 標(biāo)準(zhǔn)物質(zhì)| 實(shí)驗(yàn)試劑| 培養(yǎng)基| 菌種購買| 新聞中心| 聯(lián)系我們| 網(wǎng)站地圖

          2011-2018 中檢計量-萊耀生物@版權(quán)所有

          ? 主站蜘蛛池模板: 保定市| 丰都县| 嵊泗县| 根河市| 谷城县| 镇安县| 枣强县| 库尔勒市| 巴里| 衡水市| 广昌县| 化州市| 偃师市| 洮南市| 饶阳县| 无为县| 黄陵县| 娱乐| 霍山县| 成武县| 江川县| 岳普湖县| 利辛县| 大石桥市| 博兴县| 赞皇县| 惠水县| 泸定县| 喀喇沁旗| 湖南省| 昆山市| 万宁市| 德钦县| 闸北区| 五大连池市| 自贡市| 富平县| 浦东新区| 曲阜市| 吕梁市| 开江县|